 Effect cyclo Leu-Gly cyclic GMP-phosphodiesterase activity changes development tolerance morphine-induced antinociception catalepsy respiratory depression mydriasis biochemical basis development tolerance number models none complete tolerance drug Previous studies laboratory development complete tolerance certain morphine-induced behaviors antinociception catalepsy respiratory depression changes activity form phosphodiesterase cyclic GMP substrate cGMP-PDE activity brain areas behaviors periaqueductal gray striatum medulla present study experiments Cyclo Leu-Gly dipeptide development tolerance mg/kg morphine-naive rats morphine morphine morphine-tolerant rats cGMP-PDE activity development tolerance effects administration cyclo Leu-Gly changes cGMP-PDE activity various brain regions Differences cGMP hydrolysis brain regions morphine-tolerant animals tolerance-inhibited animals tolerance-reversed animals evidence direct involvement cGMP-PDE tolerance phenomena